Bionic Power’s purpose is to design and develop lower-body smart orthoses that improve quality of life by enhancing personal mobility and walking abilities.
Bionic Power Inc. is a Canadian, privately held company that has developed and holds IP rights on wearable technology. This technology addresses the rapidly growing market for mobility assistance in patients with knee pathologies.
Our Agilik™ smart orthosis targets patients with crouch gait (due to various conditions such as cerebral palsy, spina bifida, muscular dystrophy and other knee-extension-deficiency disorders) or hemiparesis due to stroke or polio.
Hired in Q3 2021
Former president of Dialco Medical Inc.
23 years in medical devices (clinical development, commercialization, regulatory and manufacturing).
31 years in product development
14 years of gait analysis and exoskeleton design and development experience.
Past experience with Delta Q, Ciena Networks, Nortel
Extensive public and private company CFO experience.
Mr. Garcha’s venture-capital background spans nearly two decades in the biotech, medical device, and pharmaceutical sectors. A former senior vice-president at GrowthWorks Capital, Mr. Garcha also worked at the Business Development Bank of Canada. As a VC, Mr. Garcha backed Angiotech, Anormed (sold to Genzyme) and Creo Products (sold to Kodak). Mr. Garcha earned a Bachelor of Science in Microbiology from the University of British Columbia, and an MBA from the University of Western Ontario.
Mr. de La Bruyère is the Principal of Maclab Development Group, a real estate development and investment firm.
Mr. de La Bruyère began his professional career as an associate with management consultancy McKinsey and Company and recently served as the Chairman of Viewtrak Technologies, a livestock information technology company.
Angela Saunders is an experienced sales leader, executive, and director, with over 12 years of professional service in the Orthotics & Prosthetics industry.
She has extensive insight into developing go-to-market strategies and building strong partner relationships all over the world.
As CEO of Vorum, she brought cutting-edge digital workflow solutions to the custom orthotic and prosthetic field, empowering clinicians to spend more time with their patients.
Angela holds a Bachelor of Commerce and a Bachelor of Biochemistry from Queen’s University.
FABRIZIO BROCCHIERI – DIRECTOR
Fabrizio Brocchieri is an experienced financial advisor and executive with over 25 years of practice in execution and financing of M&A transactions. He has also been chief financial officer and board member of a renewable energy company from the start-up phase until the financial sponsor exit, through the international expansion and strategic re-positioning of the sustainable E-mobility business. Fabrizio spent most of his professional career working for Deutsche Bank Corporate and Investment Banking, Intesa Sanpaolo International Banking Division and he is currently managing director of Capital Insight Partners, an independent financial advisory boutique. Fabrizio graduated from the Università Cattolica del Sacro Cuore, and lives in Milan with his wife and four children.
AARON FLORES – DIRECTOR
Aaron Flores, Ph.D. , currently serves as Vice President of Strategy and Product Development at Hanger, Inc. Aaron has led several organizations in his 14 year tenure at Hanger including Innovative Neurotronics, Surefit, and the Hanger Fabrication Network. Prior to joining Hanger, Aaron worked several years at divisions of Johnson and Johnson leading product development, strategy, and mergers and acquisitions. Aaron holds BS, MS, and PhD degrees in Engineering from the Massachusetts Institute of Technology as well as an MBA from Harvard Business School. He has published research in different fields including O&P and holds several US and international patents.
DELPHINE HANTON– DIRECTOR
After her preparatory classes, Delphine Hanton joined the Grenoble School of Management and completed her studies with an MBA in the United States. After starting her career in financial auditing at PricewaterhouseCoopers in Paris, she joined Thuasne Group as administrative and financial manager in 2008 and became administrative and financial director in 2013. In early 2016, Delphine was appointed deputy general manager, expanding her scope to include IT, legal affairs, and then regulatory affairs. Delphine was then appointed CEO of Thuasne Group in March 2020.
Dr. Condliffe’s clinical work and research are driven by an interest in improving clinical interventions to promote neuroplastic change and reduce multisystem impacts of impairments throughout the lifespan of people with cerebral palsy and other causes of long-term neurodisabilities. As a biomedical engineer, neurophysiololgist and physiatrist, she focuses on improving clinical interventions to promote neuroplastic change and reduce multi-system impacts of impairments throughout the lifespan of people. She uses technological innovations including robot-assisted walking, neurophysiologic, biomechanical and clinical tools in assessments, for rehabilitation or as assistive devices. This helps us understand the mechanisms of impairments, deliver targeted interventions, and evaluate them.
Mr. Ducottet graduated from the Ecole Nationale Supérieure d’Arts et Métiers. He began his career in 1999 in the SNECMA rocket engine design office. Matthieu then worked for 10 years in an engineering and technology consulting company. He has been involved in various missions in large companies in the aeronautics and automotive sectors (Dassault Aviation, EADS, PSA, Renault). In 2008, Mr. Ducottet joined the Thuasne group as Innovation Director and now also manages the Thuasne LAB in Lyon, responsible for digital and IoT technologies.
Tom is a Fellow of the AAOP and received the Academy’s Distinguished Practitioner Award. He was awarded the AOPA’s Lifetime Achievement Award in 2015. Tom is a Past President of the Academy and Past President for two successive years of the AOPA. Most recently he was awarded the prestigious J.E. Hanger award for Outcomes from Hanger Clinic.
Tom is Clinical Assistant Professor at the Baylor College of Medicine, Honorary Adjunct Faculty at Texas Women’s University, Chairman of the Advisory Committee of the Baylor College of Medicine’s Master of Science Program in Orthotics and Prosthetics, and is a Director in the Department of Clinical and Scientific Affairs, Hanger Clinic, a clinical research orthotist, and a practicing orthotist at Hanger Clinic.
Dr. Selber is an orthopedic surgeon who has been involved in the treatment of gait and movement disorders in pediatric, adolescent, and adult patients for more than 25 years. He specializes in conditions such as cerebral palsy, spina bifida and several neuromuscular conditions. Early in 2022, Dr. Selber joined HSS where he collaborates with the Dr. Leon Root Motion Analysis Laboratory and continues to care for ambulatory and non-ambulatory children and adults with cerebral palsy.